How effective is Benicar for High Blood Pressure? (a real world drug study)

Summary:

Overall ratings: 3.6/5
Long term ratings: 3.7/5

This is a phase IV clinical study of how effective Benicar (olmesartan medoxomil) is for High blood pressure and for what kind of people. The study is created by eHealthMe from 911 Benicar users and is updated continuously.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.

What is High blood pressure?

High blood pressure is found to be associated with 3,496 drugs and 5,229 conditions by eHealthMe. Check the latest studies of High blood pressure.


On Mar, 10, 2026

911 people are studied for taking Benicar in High blood pressure

Overall effectiveness (number of people):

Does Benicar work for your High blood pressure (overall)?

Long term (1+ years) effectiveness (number of people):

Does Benicar work for your High blood pressure (long term)?

Benicar effectiveness for High blood pressure (number of people):

Overall:
  • not at all: 8
  • somewhat: 107
  • moderate: 291
  • high: 348
  • very high: 157
Long Term:
  • not at all: 2
  • somewhat: 49
  • moderate: 200
  • high: 264
  • very high: 123

Gender of people who take Benicar for High blood pressure *:

  • female: 50.05 %
  • male: 49.95 %

Age of people who take Benicar for High blood pressure *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.22 %
  • 20-29: 1.1 %
  • 30-39: 5.6 %
  • 40-49: 15.7 %
  • 50-59: 30.74 %
  • 60+: 46.65 %

Who find Benicar more effective for High Blood Pressure?

Gender of people who take Benicar for High blood pressure *:

  • female: 49.7 %
  • male: 50.3 %

Age of people who take Benicar for High blood pressure *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.4 %
  • 20-29: 1.19 %
  • 30-39: 6.14 %
  • 40-49: 17.03 %
  • 50-59: 32.28 %
  • 60+: 42.97 %

* Approximation only. Some reports may have incomplete information.

Do you take Benicar?

- You can start a phase IV clinical trial to monitor Benicar safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on olmesartan medoxomil (the active ingredients of Benicar) and Benicar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: